Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-04

Clinical Trial Update: Decreased Insulin Regulated Aminopeptidase (IRAP) Levels in Gestational Diabetes Mellitus

View source ↗

Summary

A completed clinical trial update reports decreased levels of insulin-regulated aminopeptidase (IRAP) in gestational diabetes mellitus during pregnancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: OSMAN KÖSE, MD | Conditions: Gestational Diabetes Mellitus in Pregnancy | Status: COMPLETED